In silico-based reengineering of a murine urokinase-type plasminogen activator inhibitor as potent i

• 作 者: Ge Liu Peng Xu Mingdong Huang Jinyu Li
• 机 构: National & Local Joint Biomedical Engineering Research Center on Photodynamic Technologies,College o
• 出 处: 2019中国化学会第十五届全国计算(机)化学学术会议
• 发表日期: 2019年3期
• 关键词: uPA peptide inhibitor molecular dynamic simulation cancer therapy

　　Urokinase-type plasminogen activator(uPA) is a potential therapeutic target for cancerXREFX.1 Very recently,we reported a cyclic peptide-based inhibitor(IG-2,CPAYSRYIGC) of murine uPA with high potency and specificity(Ki=6.8 nM).2-3 However,the potency of IG-2 against human uPA(huPA) was much weaker(Ki=340 nM),hindering the clinical translation of peptide-based uPA targeting strategy.